Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-03
2010-10-26
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S070000, C546S015000, C514S278000
Reexamination Certificate
active
07820691
ABSTRACT:
Various calcium channel blockers and pharmaceutical compositions containing these compounds are disclosed. Calcium channel blockers are compounds capable of inhibiting calcium ion channels. Methods for preparing calcium channel blockers and their use as calcium channel antagonists are also disclosed.
REFERENCES:
patent: 2 064 793 (1980-08-01), None
patent: 2064793 (1980-08-01), None
patent: 24393 (1998-07-01), None
patent: WO 2008/106659 (2008-09-01), None
patent: WO 2008/109343 (2008-09-01), None
Dulenko, V.I. et al.: Synthesis of condensation products of indolo[2,3-c]pyrylium salts and beta-carbolines. Khimiya Geterot. Soed. vol. 3, pp. 363-366, 1985 ( see english translation pp. 302-305 ).
Kibalny, A.V. et al.: Tetracyclic beta-carbolines. The neuroprotector carbacetam, its derivatives and independent synthesis. Fiziologichno Aktivni Rechovini, vol. 2, pp. 23-29, 2002.
Compounds with RN 118776-13-9 and RN 123199-88-2 ( disclosed in 1989 ).
Lader et al., “Withdrawing Benzodiazepines In Primary Care,” CNS Drugs, vol. 23, 2009, pp. 19-34.
A. V. Kibal′nyi et al., “Tetracyclic β-Carbolines. The Neuroprotector Carbacetam, Its Derivatives And Countercurrent Synthesis,” Fisiolohichno aktyvni rechovyny, No. 2 (34), 2002, pp. 23-29.
Komissarov, et al., Noncoincidence of the Anxiolytic, Sedative, and Antispasmodic Properties in Harman Derivatives, Khimiko-Farmatsevticheskii Zhurnal, Mar. 1986, vol. 19, No. 3, pp. 187-191.
Komissarov, et al., Synthesis and Pharmacological Properties of 1-Alkyl-3,4-Tetramethylene-β-Carbolines, Khimiko-Farmatsevticheskii Zhurnal, Jun. 1990, vol. 23, No. 6, pp. 471-474.
Dulenko, et al., Synthesis of Condensed Derivatives of Indolo[2-3-c]pyrylium Salts and β-Carbolines, Khimlya Geterotsikicheskikh Soedinenii, Mar. 1985, No. 3, pp. 363-366.
Tolkunov, et al., Condensed Pyridine Bases. Khimiya Geterotsiklicheskikh Soedinenii, Aug. 1995, No. 8, pp. 980-984.
International Search Report dated Jul. 25, 2008 that issued in International Application No. PCT/US07/17943.
Kibal′nyi et al., Fiziiologichno aktivni rechovini, “Tetracyclic B-Carbolines, Neuroprotector Carbactetam, its Derivatives and Independent Synthesis,” No. 2 (34), pp. 23-29 (2002) (English Translation).
Tighineanu, et al., Tetrahedron, “Double Cycllsation of Phenylglycine-o-Carboxylic Acids,” No. 36, pp. 1385-1397, (1980).
Kollmar et al., Organic Syntheses, “2-Amino-3-Fluorobenzoic Acid,” vol. 10, p. 23 (2004); vol. 79, p. 196 (2002).
Holt et al., Proceedings of the Royal Society B, “Studies in Enzyme Cytochemistry II. Synthesis of Indigogenic Substrates for Esterases,” vol. 148, pp. 481-494, (Apr. 8, 1958).
Holt et al., Journal of the Chemical Society, “Vibration Frequency Correlations in Heterocyclic Molecules. Part IV. Indoxyl Derivatives,” pp. 1217-1223 (1958).
Stockmann et al., Tetrahedron, “Preparation of New Pyrido[3,4-b]thienopyrroles and pyrido[4,3-e]-thienopyridazines,” No. 64, pp. 7626-7632 (2008).
Lukic-Panin et al., Prevention of Neuronal Damage by Calcium Channel Blockers with Antioxidative Effects after Transient Focal Ischemia in Rats,Brain Research, (Aug. 2, 2007), vol. 1176, pp. 143-150.
Zhang et al., N-methyl-D-asparate Receptor and L-type Voltage-Gated Ca2+Channel Antagonists Suppress the Release of Cytochrome C and the Expression of Procaspase-3 in Rat Hippocampus after Global Ischemia,Neuroscience Letters, (May 13, 2002), vol. 328, pp. 265-268.
Ba{hacek over (g)}irici et al., M. Ö., Anticonvulsant Effects of Nimodipine on Penicillin-Induced Epileptoform Activity,Acta Neurobiologiae Experimentalis, (Jun. 1, 2006), vol. 66, pp. 123-128.
Yagami et al., Protective Effects of a Selective L-Type Voltage-Sensitive Calcium Channel Blocker, S-312-d, on Neuronal Cell Death,Biochemical Pharmacology, (Nov. 3, 2003), vol. 67, pp. 1153-1165.
Rose et al., Efficacy of MEM 1003, A Novel Calcium Channel Blocker, in Delay and Trace Eyeblink Conditioning in Older Rabbits,Neurobioogy of Aging, (Apr. 18, 2006), vol. 28, pp. 766-773.
Shutov et al., The Effect of Nimodipine on Calcium Homeostasis and Pain Sensitivity in Diabetic Rats,Cellular and Molecular Neurobiology(Jul. 12, 2006), vol. 26, pp. 1541-1557.
Mamczarz et al., The Ca+2Channel Blockade Changes the Behavioral and Biochemical Effects of Immobilization Stress,Neuropsychopharmacology, (Jul. 21, 1998), vol. 20, pp. 248-254.
Handbook of Pharmaceutical Salts, Wiley-VCH (Stahl et al. eds., 2002).
J. Striessnig et al., ‘Role of Voltage-Gated L-Type CA2+ Channel Isoforms for Brain Function’, Biochemical Society 2006, Ion Channels: Communication Across Membranes.
Nikolyukin Yuri
Shcherbakova Irina
Aulakh Charanjit S
MediProPharma, Inc.
Stoel Rives LLP
LandOfFree
Indoloquinoline compounds as calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoloquinoline compounds as calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoloquinoline compounds as calcium channel blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4242376